永新光學(603297.SH):先後承擔“嫦娥二號”、“嫦娥三號”、“嫦娥四號”星載光學鏡頭的製造
格隆匯6月13日丨永新光學(603297.SH)在投資者互動平台表示,公司積極服務國家科學儀器強國戰略和航空航天重大工程戰略,多次參與國家重大工程和項目,先後承擔“嫦娥二號”、“嫦娥三號”、“嫦娥四號”星載光學鏡頭的製造,並於2023年獲由教育部頒發的科學技術進步獎“一等獎”。 此外,公司承製國內首台“太空顯微實驗儀”,於2021年4月29日伴隨“天和”核心艙成功入駐中國空間站,以其優異的性能及穩定的質量為空間站航天醫學、太空生命科學等技術研究提供支撐。同年12月9日,中國航天員葉光富使用“太空顯微實驗儀”展示失重條件下心肌細胞跳動實驗,完成天宮課堂實驗首秀,全球超過7200萬人在線觀看,入選中國年度十大科普事件,社會影響顯著。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.